16,809 reports of this reaction
12.6% of all SOMATROPIN reports
#1 most reported adverse reaction
DRUG DOSE OMISSION BY DEVICE is the #1 most commonly reported adverse reaction for SOMATROPIN, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 16,809 FDA adverse event reports linking SOMATROPIN to DRUG DOSE OMISSION BY DEVICE. This represents approximately 12.6% of all 133,576 adverse event reports for this drug.
SOMATROPIN has an overall safety score of 78 out of 100. Patients taking SOMATROPIN who experience drug dose omission by device should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG DOSE OMISSION BY DEVICE is a frequently reported adverse event for SOMATROPIN, accounting for a significant proportion of all reports.
In addition to drug dose omission by device, the following adverse reactions have been reported for SOMATROPIN:
The following drugs have also been linked to drug dose omission by device in FDA adverse event reports:
DRUG DOSE OMISSION BY DEVICE has been reported as an adverse event in 16,809 FDA reports for SOMATROPIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG DOSE OMISSION BY DEVICE accounts for approximately 12.6% of all adverse event reports for SOMATROPIN, making it one of the most commonly reported side effect.
If you experience drug dose omission by device while taking SOMATROPIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.